Cargando…

Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial

OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants w...

Descripción completa

Detalles Bibliográficos
Autores principales: Azadbakht, Leila, Fard, Nafiseh Rashidi Pour, Karimi, Majid, Baghaei, Mohammad Hassan, Surkan, Pamela J., Rahimi, Majid, Esmaillzadeh, Ahmad, Willett, Walter C.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005461/
https://www.ncbi.nlm.nih.gov/pubmed/20843978
http://dx.doi.org/10.2337/dc10-0676
_version_ 1782194094507819008
author Azadbakht, Leila
Fard, Nafiseh Rashidi Pour
Karimi, Majid
Baghaei, Mohammad Hassan
Surkan, Pamela J.
Rahimi, Majid
Esmaillzadeh, Ahmad
Willett, Walter C.
author_facet Azadbakht, Leila
Fard, Nafiseh Rashidi Pour
Karimi, Majid
Baghaei, Mohammad Hassan
Surkan, Pamela J.
Rahimi, Majid
Esmaillzadeh, Ahmad
Willett, Walter C.
author_sort Azadbakht, Leila
collection PubMed
description OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants were randomly assigned to a control diet or the DASH eating pattern. RESULTS: After following the DASH eating pattern, body weight (P = 0.007) and waist circumference (P = 0.002) reduced significantly. Fasting blood glucose levels and A1C decreased after adoption of the DASH diet (−29.4 ± 6.3 mg/dl; P = 0.04 and −1.7 ± 0.1%; P = 0.04, respectively). After the DASH diet, the mean change for HDL cholesterol levels was higher (4.3 ± 0.9 mg/dl; P = 0.001) and LDL cholesterol was reduced (−17.2 ± 3.5 mg/dl; P = 0.02). Additionally, DASH had beneficial effects on systolic (−13.6 ± 3.5 vs. −3.1 ± 2.7 mmHg; P = 0.02) and diastolic blood pressure (−9.5 ± 2.6 vs. −0.7 ± 3.3 mmHg; P = 0.04). CONCLUSIONS: Among diabetic patients, the DASH diet had beneficial effects on cardiometabolic risks.
format Text
id pubmed-3005461
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-30054612012-01-01 Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial Azadbakht, Leila Fard, Nafiseh Rashidi Pour Karimi, Majid Baghaei, Mohammad Hassan Surkan, Pamela J. Rahimi, Majid Esmaillzadeh, Ahmad Willett, Walter C. Diabetes Care Original Research OBJECTIVE: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) eating pattern on cardiometabolic risks in type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A randomized crossover clinical trial was undertaken in 31 type 2 diabetic patients. For 8 weeks, participants were randomly assigned to a control diet or the DASH eating pattern. RESULTS: After following the DASH eating pattern, body weight (P = 0.007) and waist circumference (P = 0.002) reduced significantly. Fasting blood glucose levels and A1C decreased after adoption of the DASH diet (−29.4 ± 6.3 mg/dl; P = 0.04 and −1.7 ± 0.1%; P = 0.04, respectively). After the DASH diet, the mean change for HDL cholesterol levels was higher (4.3 ± 0.9 mg/dl; P = 0.001) and LDL cholesterol was reduced (−17.2 ± 3.5 mg/dl; P = 0.02). Additionally, DASH had beneficial effects on systolic (−13.6 ± 3.5 vs. −3.1 ± 2.7 mmHg; P = 0.02) and diastolic blood pressure (−9.5 ± 2.6 vs. −0.7 ± 3.3 mmHg; P = 0.04). CONCLUSIONS: Among diabetic patients, the DASH diet had beneficial effects on cardiometabolic risks. American Diabetes Association 2011-01 2010-09-15 /pmc/articles/PMC3005461/ /pubmed/20843978 http://dx.doi.org/10.2337/dc10-0676 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Azadbakht, Leila
Fard, Nafiseh Rashidi Pour
Karimi, Majid
Baghaei, Mohammad Hassan
Surkan, Pamela J.
Rahimi, Majid
Esmaillzadeh, Ahmad
Willett, Walter C.
Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title_full Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title_fullStr Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title_full_unstemmed Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title_short Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients: A randomized crossover clinical trial
title_sort effects of the dietary approaches to stop hypertension (dash) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005461/
https://www.ncbi.nlm.nih.gov/pubmed/20843978
http://dx.doi.org/10.2337/dc10-0676
work_keys_str_mv AT azadbakhtleila effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT fardnafisehrashidipour effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT karimimajid effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT baghaeimohammadhassan effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT surkanpamelaj effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT rahimimajid effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT esmaillzadehahmad effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial
AT willettwalterc effectsofthedietaryapproachestostophypertensiondasheatingplanoncardiovascularrisksamongtype2diabeticpatientsarandomizedcrossoverclinicaltrial